Clinical Trials Logo

Clinical Trial Summary

Current therapeutic options for a well-recognized group of patients with anginal symptoms—a positive exercise tolerance testing, SPECT or perfusion defect in MRI but angiographically normal coronary arteries—are limited. The condition, referred to as microvascular angina (MVA) or cardiac syndrome X, is not as benign as originally reported—patients presenting with unstable angina and nonobstructive atherosclerotic coronary artery disease have a 2% risk of death or myocardial infarction at 30 days of follow-up. It is more common in women in whom the first presentation of angina occurs either perimenopausally or postmenopausally. Aberrant flow-mediated coronary vasomotion is pivotal in the pathogenesis (systemic) impairment in endothelial function. Indeed, some centers use systemic assessments of vascular function in their diagnostic pathways for this group of women. It was recently suggested that endothelial dysfunction may lead to myocardial ischemia.

In the present study, the investigators tested the hypothesis that udenafil offers dual benefits of improving vascular function and lessening ischemia in women with angina, perfusion defect in cardiac MRI, and normal coronary arteries.


Clinical Trial Description

The aim of this study is that udenafil offers dual benefits of improving vascular function and lessening ischemia in women with microvascular angina, perfusion defect in cardiac MRI, and normal coronary arteries.

The UMPIRE trial is a multi-center, prospective, randomized, placebo controlled trial, designed to evaluate the effect of udenafil in improvement of myocardial stress perfusion defect in cardiac MRI, in women patients with microvascular angina. A total of 70 patients will be randomized to udenafil(100 mg q d) or placebo treatment. The primary end point of the study is Change of perfusion defect over 25% of baseline defect in adenosine-stress cardiac MRI after 3-month treatment. The secondary endpoints of this study are change of perfusion defect less than 25% of baseline defect in adenosine-stress cardiac MRI after 3-month treatment, decrement of frequency of chest pain, improvement of ST-depression in stress test, improvement of duke score in stress test, improvement of QoL assessment by SF-36 questionnaire, improvement of sexual dysfunction assessment by BISF-W self-questionnaire and improvement of biomarkers foe endothelial function. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01769482
Study type Interventional
Source Samsung Medical Center
Contact Sung-Ji Park, M.D.,Ph.D.
Phone 82-2-3410-0887
Email tyche.park@gmail.com
Status Recruiting
Phase Phase 4
Start date December 2011
Completion date December 2014

See also
  Status Clinical Trial Phase
Completed NCT02147067 - Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA) Phase 2
Completed NCT06306066 - Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome
Recruiting NCT05288361 - The DISCOVER INOCA Prospective Multi-center Registry
Active, not recruiting NCT04777045 - Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial Phase 3
Completed NCT04097314 - Precision Medicine With Zibotentan in Microvascular Angina Phase 2
Recruiting NCT06025994 - Standardizing the Management of Patients With Coronary Microvascular Dysfunction N/A
Recruiting NCT04598308 - EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial
Completed NCT03193294 - CORonary MICrovascular Angina (CorMicA) N/A
Not yet recruiting NCT02284048 - Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina Phase 4
Recruiting NCT00921856 - Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD) N/A
Completed NCT02602600 - Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis Phase 4
Recruiting NCT06070662 - Non-invasive Diagnosis of Coronary Microvascular Disease: Pilot Study
Terminated NCT02914834 - Acupuncture for Individuals With Stable Angina N/A
Completed NCT04508998 - PRIZE ET Sub-Study N/A
Recruiting NCT05294887 - Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Phase 4
Completed NCT02095964 - HDL-C in Cardiac Syndrome X N/A
Recruiting NCT06401291 - Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries N/A
Completed NCT04391491 - Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot Study
Recruiting NCT05635994 - Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)
Recruiting NCT05313919 - Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis